Acetop UK Reports 2025 Loss as Trading Volumes Drop to $9.5 Billion
Acetop Financial Limited posted a £35,691 pretax loss in 2025 after revenue declined and trading volumes fell 21% to about $9.5 billion.
简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:Genesis Global Capital, a cryptocurrency lender, is expected to file for bankruptcy as soon as this week, according to Bloomberg News, citing individuals familiar with the issue.

Genesis Global Capital, a cryptocurrency lender, is expected to file for bankruptcy as soon as this week, according to Bloomberg News, citing individuals familiar with the issue.
For weeks, a bankruptcy filing was anticipated after the business suspended client redemptions on Nov. 16 after the collapse of major cryptocurrency exchange FTX.
Following FTX's demise in November, numerous victims emerged, including crypto lender BlockFi and Core Scientific Inc, one of the largest publicly listed crypto mining businesses in the United States, both of which filed for bankruptcy protection in the months that followed.
According to the Bloomberg story, Genesis, its parent company Digital Currency Group, and creditors have exchanged various offers but have yet to reach a deal. Kirkland & Ellis and Proskauer Rose have been counseling groups of creditors.
Genesis did not immediately reply to a request for comment from Reuters.
Genesis is also at odds with Gemini, which was created by identical twin crypto pioneers Cameron and Tyler Winklevoss.
Gemini, in collaboration with Genesis, created a crypto loan product called Earn and now claims Genesis owes it $900 million in connection with that product.
The Assets and Exchange Commission accused Genesis and Gemini last week of unlawfully marketing securities to hundreds of thousands of investors through their crypto lending scheme.
Keep an eye out for more cryptocurrency news.
You may download the WikiFX App for your mobile device from the download link below, as well as the App Store or Google Play Store.
Link to download: https://www.wikifx.com/en/download.html

Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.

Acetop Financial Limited posted a £35,691 pretax loss in 2025 after revenue declined and trading volumes fell 21% to about $9.5 billion.

ORCA MARKETS, a Saint Lucia-based forex broker, is reportedly facing many complaints from users as of mid 2026. They frequently complain about the app that refuses to work properly for hours, preventing them from taking the right position to unleash market movement. Complaints have been made about fund losses and deposit failures on the platform. These allegations made it imperative to investigate the broker on different aspects, including the regulatory oversight. We have done so in this ORCA MARKETS review article.

Did your attempt to withdraw funds from the LOYAL PRIMUS platform lead to your account deactivation by the broker? Did the broker prevent you from withdrawing when you made profits? Did the broker cancel your withdrawal application by accusing you of suspicious trading activity? These allegations have grown in numbers on independent broker review tools such as WikiFX. In this LOYAL PRIMUS review article, we have examined all these allegations thoroughly.

Failed to withdraw funds from the Eurotrader platform despite repeated requests? Do you fail to trade due to persistent login issues? Has the customer support service failed to resolve the issue? Did you also face wide spreads that led to a massive profit reduction? All these user allegations have become strong headlines on broker review platforms such as WikiFX. Through this Eurotrader review article, we have shared the user allegations along with a regulatory overview.